atypical antipsychotics got slapped hard new study archives general psychiatry delivered sizable blow medications finding yielded clinical benefit watchful waiting placebo treating dementia atypical antipsychotics studies associated higher costs olanzapine zyprexa particularly poorly patients taking zyprexa higher costs yet activities daily living personal care chores household activities etc score significantly worse patients taking placebo patients taking risperidone risperdal quetiapine seroquel also scored worse patients receiving placebo measure though zyprexa patients lowest overall scores addition zyprexa patients rated significantly dependent caregivers patients taking placebo authors said secondary finding patients taking olanzapine scored worse activities daily living measure patients treated watchful waiting likely represents greater level combination sedation gait disturbances behaviorally inhibiting adverse effects drug ouch may recall class medications marketed label dementia example see prior post complete links documentaton lilly pushed zyprexa dementia alzheimer let forget antipsychotic meds linked teeny little side effect known death older patients dementia well let see i straight large number dementia patients placed expensive drugs scant evidence efficacy linked increased rate death uh strike anybody else r academics say surely academic psychiatrists aware fact atypical antipsychotics poorly supported treating dementia highly educated objective scientists pass along objective evidence world write things like journal current psychiatry sgas atypical antipsychotics remain first therapeutic option psychosis agitation alzheimer patients phew good thing people turn objective unbiased scientists realistic appraisal research literature right i think golden goblet nomination safely issued authors piece current psychiatry really read earlier post topic article mind bogglingly bad